This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aandahl, E. M., Michaelsson, J., Moretto, W. J., Hecht, F. M., and Nixon, D. F. (2004). Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454-2459.
Ackerman, A. L., and Cresswell, P. (2004). Cellular mechanisms governing cross- presentation of exogenous antigens. Nat. Immunol. 5:678-684.
Ackerman, A. L., Kyritsis, C., Tampé, R., and Cresswell, P. (2003). Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. U. S. A. 100:12889-12894.
Ackerman, A. L., Kyritsis, C., Tampé, R., and Cresswell, P. (2005). Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat. Immunol. 6:107-113.
Akakura, S., Singh, S., Spataro, M., Akakura, R., Kim, J. I., Albert, M. L., and Birge, R. B. (2004). The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phago- cytosis of apoptotic cells. Exp. Cell. Res. 292:403-416.
Aladdin, H., Ullum, H., Dam Nielsen, S., Espersen, C., Mathiesen, L., Katzenstein, T. L., Gerstoft, J., Skinhoj, P., and Pedersen, B. K. (2000). Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo- controlled trial. J. Infect. Dis. 181:1148-1152.
Albert, M. L. (2004). Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat. Rev. Immunol. 4:223-231.
Albert, M. L., Jegathesan, M., and Darnell, R. B. (2001). Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2:1010- 1017.
Albert, M. L., Pearce, S. F., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., and Bhardwaj, N. (1998a). Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359-1368.
Albert, M. L., Sauter, B., and Bhardwaj, N. (1998b). Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89.
Andre, F., Chaput, N., Schartz, N. E., Flament, C., Aubert, N., Bernard, J., Lemonnier, F., Raposo, G., Escudier, B., Hsu, D. H., Tursz, T., Amigorena, S., Angevin, E., and Zitvogel, L. (2004). Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172:2126- 2136.
Andrieu, M., Chassin, D., Desoutter, J. F., Bouchaert, I., Hanau, D., Guillet, J. G., and Hosmalin, A. (2001). HIV-1 Nef protein induces a down-regulation of the dendritic cell surface expression of MHC class I and impairs antigen presentation to CTL. AIDS Res. Hum. Retroviruses 17:1365-1370.
Armstrong, W. S., and Kazanjian, P. (2001). Use of cytokines in human immuno- deficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2. Clin. Infect. Dis. 32:766-773.
Babbitt, B. P., Allen, P. M., Matsueda, G., Haber, E., and Unanue, E. R. (1985). The binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317:359-361.
Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392:245-252.
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., and Palucka, K. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
Bausinger, H., Lipsker, D., Ziylan, U., Manie, S., Briand, J. P., Cazenave, J. P., Muller, S., Haeuw, J. F., Ravanat, C., de la Salle, H., and Hanau, D. (2002). Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32:3708-3713.
Bedford, P., Garner, K., and Knight, S. C. (1999). MHC class II molecules transferred between allogeneic dendritic cells stimulate primary mixed leukocyte reactions. Int. Immunol. 11:1739-1744.
Beignon, A. S., McKenna, K., Skoberne, M., Manches, O., Dasilva, I., Kavanagh, D. G., Larsson, M., Gorelick, R. J., Lifson, J. D., and Bhardwaj, N. (2005). Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115:3265-3275.
Bellone, M., Iezzi, G., Rovere, P., Galati, G., Ronchetti, A., Protti, M. P., Davoust, J., Rugarli, C., and Manfredi, A. A. (1997). Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:5391-5399.
Belz, G. T., Shortman, K., Bevan, M. J., and Heath, W. R. (2005). CD8{alpha}+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175:196-200.
Berard, F., Blanco, P., Davoust, J., Neidhart-Berard, E. M., Nouri-Shirazi, M., Taquet, N., Rimoldi, D., Cerottini, J. C., Banchereau, J., and Palucka, A. K. (2000). Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med. 192:1535-1544.
Bevan, M. J. (1976). Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283-1288.
Bevan, M. J. (1987). Antigen recognition. Class discrimination in the world of immunology. Nature 325:192-194.
Binder, R. J., and Srivastava, P. K. (2005). Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat. Immunol. 6:593-599.
Blachere, N. E., Darnell, R. B., and Albert, M. L. (2005). Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol. 3:e185.
Blander, J. M., and Medzhitov, R. (2004). Regulation of phagosome maturation by signals from toll-like receptors. Science 304:1014-1018.
Blankson, J. N., Persaud, D., and Siliciano, R. F. (2002). The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557-593.
Boes, M., Cuvillier, A., and Ploegh, H. (2004). Membrane specializations and endosome maturation in dendritic cells and B cells. Trends Cell. Biol. 14:175- 183.
Boonstra, A., Asselin-Paturel, C., Gilliet, M., Crain, C., Trinchieri, G., Liu, Y. J., and O’Garra, A. (2003). Flexibility of mouse classical and plasmacytoid- derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197:101-109.
Buseyne, F., Le Gall, S., Boccaccio, C., Abastado, J. P., Lifson, J. D., Arthur, L. O., Riviere, Y., Heard, J. M., and Schwartz, O. (2001). MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 7:344-349.
Cardinaud, S., Moris, A., Fevrier, M., Rohrlich, P. S., Weiss, L., Langlade- Demoyen, P., Lemonnier, F. A., Schwartz, O., and Habel, A. (2004). Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J. Exp. Med. 199:1053-1063.
Chen, W., Masterman, K. A., Basta, S., Mansour Haeryfar, S. M., Dimopoulos, N., Knowles, B., Bennink, J. R., and Yewdell, J. W. (2004). Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon. Eur. J. Immunol. 34:194-199.
Chougnet, C. (2003). Role of CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells. J. Leukoc. Biol. 74:702-709.
Chougnet, C., Shearer, G. M., and Landay, A. L. (2002). The role of antigen- presenting cells in HIV pathogenesis. Curr. Infect. Dis. Rep. 4:266-271.
Chow, A., Toomre, D., Garrett, W., and Mellman, I. (2002). Dendritic cell matu- ration triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418:988-994.
Chun, T. W., Engel, D., Mizell, S. B., Hallahan, C. W., Fischette, M., Park, S., Davey, R. T., Jr., Dybul, M., Kovacs, J. A., Metcalf, J. A., Mican, J. M., Berrey, M. M., Corey, L., Lane, H. C., and Fauci, A. S. (1999). Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1- infected patients receiving highly active anti-retroviral therapy. Nat. Med. 5:651-655.
Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D., and Baltimore, D. (1998). HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401.
Dalod, M., Dupuis, M., Deschemin, J.-C., Goujard, C., Deveau, C., Meyer, L., Ngo, N., Rouzioux, C., Guillet, J.-G., Delfraissy, J.-F., Sinet, M., and Venet, A. (1999). Weak anti-HIV CD8+ T-cell effector activity in HIV primary infection. J. Clin. Invest. 104:1431-1439.
Day, P. M., Yewdell, J. W., Porgador, A., Germain, R. N., and Bennink, J. R. (1997). Direct delivery of exogenous MHC class I molecule-binding oligo- peptides to the endoplasmic reticulum of viable cells. Proc. Natl. Acad. Sci. U. S. A. 94:8064-8069.
Delamarre, L., Holcombe, H., and Mellman, I. (2003). Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198:111-122.
den Haan, J. M., and Bevan, M. J. (2002). Constitutive versus activation- dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J. Exp. Med. 196:817-827.
den Haan, J. M., Lehar, S. M., and Bevan, M. J. (2000). CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685- 1696.
Donaghy, H., Stebbing, J., and Patterson, S. (2004). Antigen presentation and the role of dendritic cells in HIV. Curr. Opin. Infect. Dis. 17:1-6.
Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., and Haase, A. T. (1993). Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359-362.
Estaquier, J., Idziorek, T., De Bels, F., Barré-Sinoussi, F., Hurtrel, B., Aubertin, A.-M., Venet, A., Mehtali, M., Muchmore, E., Michel, P., Mouton, Y., Girard, M., and Ameisen, J.-C. (1994). Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc. Natl. Acad. Sci. U. S. A. 91:9431-9435.
Fantuzzi, L., Purificato, C., Donato, K., Belardelli, F., and Gessani, S. (2004). Human immunodeficiency virus type 1 gp120 induces abnormal maturation and functional alterations of dendritic cells: a novel mechanism for AIDS pathogenesis. J. Virol. 78:9763-9772.
Fonteneau, J. F., Kavanagh, D. G., Lirvall, M., Sanders, C., Cover, T. L., Bhardwaj, N., and Larsson, M. (2003). Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood 102:4448-4455.
Fonteneau, J. F., Larsson, M., Beignon, A. S., McKenna, K., Dasilva, I., Amara, A., Liu, Y. J., Lifson, J. D., Littman, D. R., and Bhardwaj, N. (2004). Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78:5223-5232.
Freigang, S., Egger, D., Bienz, K., Hengartner, H., and Zinkernagel, R. M. (2003). Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc. Natl. Acad. Sci. U. S. A. 100:13477-13482.
Gallucci, S., Lolkema, M., and Matzinger, P. (1999). Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1249-1255.
Germain, R. N., Castellino, F., Han, R., Reis e Sousa, C., Romagnoli, P., Sadegh- Nasseri, S., and Zhong, G. M. (1996). Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules. Immunol. Rev. 151:5-30.
Gil-Torregrosa, B. C., Lennon-Dumenil, A. M., Kessler, B., Guermonprez, P., Ploegh, H. L., Fruci, D., van Endert, P., and Amigorena, S. (2004). Control of cross-presentation during dendritic cell maturation. Eur. J. Immunol. 34:398- 407.
Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F. P., and Steinman, R. M. (2004). HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. U. S. A. 101:7669-7674.
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., Van Endert, P., and Amigorena, S. (2003). ER-phagosome fusion defines an MHC class I cross- presentation compartment in dendritic cells. Nature 425:397-402.
Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S. (2002). Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621-667.
Hanada, K., Yewdell, J. W., and Yang, J. C. (2004). Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427:252-256.
Harshyne, L. A., Watkins, S. C., Gambotto, A., and Barratt-Boyes, S. M. (2001). Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. 166:3717-3723.
Harshyne, L. A., Zimmer, M. I., Watkins, S. C., and Barratt-Boyes, S. M. (2003). A role for class A scavenger receptor in dendritic cell nibbling from live cells. J. Immunol. 170:2302-2309.
Heath, W. R., and Carbone, F. R. (2001). Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1:126-134.
Heath, W. R., Belz, G. T., Behrens, G. M., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., and Villadangos, J. A. (2004). Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199:9-26.
Heeney, J. L., Beverley, P., McMichael, A., Shearer, G., Strominger, J., Wahren, B., Weber, J., and Gotch, F. (1999). Immune correlates of protection from HIV and AIDS - more answers but yet more questions. Immunol. Today 20:247-251.
Henson, P. M., Bratton, D. L., and Fadok, V. A. (2001). The phosphatidylserine receptor: a crucial molecular switch? Nat. Rev. Mol. Cell. Biol. 2:627-633.
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., and Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
Hosmalin, A., Samri, A., Dumaurier, M. J., Dudoit, Y., Oksenhendler, E., Karmochkine, M., Autran, B., Wain-Hobson, S., and Cheynier, R. (2001). HIV-specific effector CTL and HIV-producing cells co-localize in white pulps and germinal centers from infected patients. Blood 97:2695-2701.
Houde, M., Bertholet, S., Gagnon, E., Brunet, S., Goyette, G., Laplante, A., Princiotta, M. F., Thibault, P., Sacks, D., and Desjardins, M. (2003). Phagosomes are competent organelles for antigen cross-presentation. Nature 425:402-406.
Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. (1994). Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961-965.
Huang, J. F., Yang, Y., Sepulveda, H., Shi, W., Hwang, I., Peterson, P. A., Jackson, M. R., Sprent, J., and Cai, Z. (1999). TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 286:952-954.
Huang, F. P., Platt, N., Wykes, M., Major, J. R., Powell, T. J., Jenkins, C. D., and MacPherson, G. G. (2000). A discrete subpopulation of dendritic cells trans- ports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435-444.
Hudrisier, D., Riond, J., Mazarguil, H., Gairin, J. E., and Joly, E. (2001). Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J. Immunol. 166:3645-3649.
Hugues, S., Mougneau, E., Ferlin, W., Jeste, D., Hofman, P., Homann, D., Beaudoin, L., Schrike, C., Von Herrath, M., Lehuen, A., and Glaichenhaus, N. (2002). Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 16:169-181.
Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., Takahara, K., Steinman, R. M., and Inaba, K. (2002). The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289-1302.
Joly, E., and Hudrisier, D. (2003). What is trogocytosis and what is its purpose? Nat. Immunol. 4:815.
Jung, S., Unutmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., Pamer, E. G., Littman, D. R., and Lang, R. A. (2002). In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17:211- 220.
Kawamura, T., Gatanaga, H., Borris, D. L., Connors, M., Mitsuya, H., and Blauvelt, A. (2003). Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells. J. Immunol. 170:4260-4266.
Kedl, R. M., Schaefer, B. C., Kappler, J. W., and Marrack, P. (2002). T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat. Immunol. 3:27-32.
Kinter, A. L., Hennessey, M., Bell, A., Kern, S., Lin, Y., Daucher, M., Planta, M., McGlaughlin, M., Jackson, R., Ziegler, S. F., and Fauci, A. S. (2004). CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200:331-343.
Kloetzel, P. M., and Ossendorp, F. (2004). Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 16:76-81.
Knight, S. C., Iqball, S., Roberts, M. S., Macatonia, S., and Bedford, P. A. (1998). Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur. J. Immunol. 28:1636-1644.
Kornfeld, C., Ploquin, M. J., Pandrea, I., Faye, A., Onanga, R., Apetrei, C., Poaty- Mavoungou, V., Rouquet, P., Estaquier, J., Mortara, L., Desoutter, J. F., Butor, C., Le Grand, R., Roques, P., Simon, F., Barre-Sinoussi, F., Diop, O. M., and Muller-Trutwin, M. C. (2005). Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 115:1082-1091.
Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., and Rock, K. L. (1993). Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. U. S. A. 90:4942-4946.
Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F. A. P., and Kosaka, H. (1996). Constitutive class-I restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:923-930.
Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., and Miller, J. F. A. P. (1999). CD8 T cell ignorance of tolerance to islet Ags depends on Ag dose. Proc. Natl. Acad. Sci. U. S. A. 96:12703-12707.
Lanzavecchia, A., and Sallusto, F. (2001). The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13:291-298.
Lapenta, C., Santini, S. M., Logozzi, M., Spada, M., Andreotti, M., Di Pucchio, T., Parlato, S., and Belardelli, F. (2003). Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFNalpha. J. Exp. Med. 198:361-367.
Larsson, M., Fonteneau, J. F., Lirvall, M., Haslett, P., Lifson, J. D., and Bhardwaj, N. (2002). Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. AIDS 16:1319-1329.
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., and Tough, D. F. (2003). Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4:1009-1015.
Lelouard, H., Gatti, E., Cappello, F., Gresser, O., Camosseto, V., and Pierre, P. (2002). Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 417:177-182.
Letvin, N. L., and Walker, B. D. (2003). Immunopathogenesis and immuno- therapy in AIDS virus infections. Nat. Med. 9:861-866.
Levy, Y., Durier, C., Krzysiek, R., Rabian, C., Capitant, C., Lascaux, A. S., Michon, C., Oksenhendler, E., Weiss, L., Gastaut, J. A., Goujard, C., Rouzioux, C., Maral, J., Delfraissy, J. F., Emilie, D., and Aboulker, J. P. (2003). Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial. AIDS 17:343-351.
Lilley, B. N., and Ploegh, H. L. (2005). Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol. Rev. 207:126-144.
Lizee, G., Basha, G., Tiong, J., Julien, J. P., Tian, M., Biron, K. E., and Jefferies, W. A. (2003). Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4:1065-1073.
Lutz, M. B., and Schuler, G. (2002). Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:445-449.
Ma, X., and Montaner, L. J. (2000). Proinflammatory response and IL-12 expression in HIV-1 infection. J. Leukoc. Biol. 68:383-390.
Macagno, A., Gilliet, M., Sallusto, F., Lanzavecchia, A., Nestle, F. O., and Groettrup, M. (1999). Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 29:4037- 4042.
Mallard, F., Antony, C., Tenza, D., Salamero, J., Goud, B., and Johannes, L. (1998). Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J. Cell. Biol. 143:973-990.
Marañón, C., Desoutter, J. F., Hoeffel, G., Cohen, W., Hanau, D., and Hosmalin, A. (2004). Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 101:6092-6097.
Marshall, J., Chehimi, J., Gri, G., Kostman, J., Montaner, L., and Trinchieri, G. (1999). The IL-12-mediated pathway of immune events is dysfunctional in HIV-infected individuals. Blood 94:1003-1011.
Martin, E., O’Sullivan, B., Low, P., and Thomas, R. (2003). Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18:155-167.
Masse, D., Voisine, C., Henry, F., Cordel, S., Barbieux, I., Josien, R., Meflah, K., Gregoire, M., and Lieubeau, B. (2002). Increased vaccination efficiency with apoptotic cells by silica-induced, dendritic-like cells. Cancer Res. 62:1050- 1056.
Matsuo, M., Nagata, Y., Sato, E., Atanackovic, D., Valmori, D., Chen, Y. T., Ritter, G., Mellman, I., Old, L. J., and Gnjatic, S. (2004). IFN-{gamma} enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation. Proc. Natl. Acad. Sci. U. S. A. 101:14467- 14472.
Matzinger, P. (2002). The danger model: a renewed sense of self. Science 296:301-305.
McIlroy, D., and Gregoire, M. (2003). Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact. Cancer Immunol. Immunother. 52:583-591.
McIlroy, D., Autran, B., Cheynier, R., Wain-Hobson, S., Clauvel, J.-P., Oksenhendler, E., Debre, P., and Hosmalin, A. (1995). Dendritic cell and CD4+ T lymphocyte infection frequency in spleens of HIV-positive patients. J. Virol. 69:4737-4745.
Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P., and Tough, D. F. (2002). Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99:3263-3271.
Morelli, A. E., Larregina, A. T., Shufesky, W. J., Zahorchak, A. F., Logar, A. J., Papworth, G. D., Wang, Z., Watkins, S. C., Falo, L. D., Jr., and Thomson, A. W. (2003). Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101:611-620.
Moris, A., Nobile, C., Buseyne, F., Porrot, F., Abastado, J. P., and Schwartz, O. (2004). DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103:2648-2654.
Nair, S., Zhou, F., Reddy, R., Huang, L., and Rouse, B. T. (1992). Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J. Exp. Med. 175:609-612.
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., and Lanzavecchia, A. (2005). Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6:769-776.
Neijssen, J., Herberts, C., Drijfhout, J. W., Reits, E., Janssen, L., and Neefjes, J. (2005). Cross-presentation by intercellular peptide transfer through gap junctions. Nature 434:83-88.
Niedermann, G., Geier, E., Lucchiari-Hartz, M., Hitziger, N., Ramsperger, A., and Eichmann, K. (1999). The specificity of proteasomes: impact on MHC class I processing and presentation of antigens. Immunol. Rev. 172:29-48.
Norbury, C. C., Malide, D., Gibbs, J. S., Bennink, J. R., and Yewdell, J. W. (2002). Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat. Immunol. 3:265-271.
Norbury, C. C., Basta, S., Donohue, K. B., Tscharke, D. C., Princiotta, M. F., Berglund, P., Gibbs, J., Bennink, J. R., and Yewdell, J. W. (2004). CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304:1318- 1321.
O’Garra, A., and Vieira, P. (2004). Regulatory T cells and mechanisms of immune system control. Nat. Med. 10:801-805.
Pantaleo, G., Graziosi, C., Butini, L., Pizzo, P. A., Schnittman, S. M., Kotler, D. P., and Fauci, A. S. (1991). Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 88:9838- 9842.
Pantaleo, G., and Koup, R. A. (2004). Correlates of immune protection in HIV-1 infection: what we know, what we don’t know, what we should know. Nat. Med. 10:806-810.
Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., and Harding, C. V. (1993). Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-362.
Philpott, D. J., and Girardin, S. E. (2004). The role of Toll-like receptors and Nod proteins in bacterial infection. Mol. Immunol. 41:1099-1108.
Pires, A., Nelson, M., Pozniak, A. L., Fisher, M., Gazzard, B., Gotch, F., and Imami, N. (2005). Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy. J. Immune Based Ther. Vaccines 3:7.
Pozzi, L. A., Maciaszek, J. W., and Rock, K. L. (2005). Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J. Immunol. 175:2071- 2081.
Propato, A., Cutrona, G., Francavilla, V., Ulivi, M., Schiaffella, E., Landt, O., Dunbar, R., Cerundolo, V., Ferrarini, M., and Barnaba, V. (2001). Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross- priming. Nat. Med. 7:807-813.
Ramirez, M. C., and Sigal, L. J. (2002). Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol. 169:6733-6742.
Rammensee, H., Friede, T., and Stevanovic, S. (1995). MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228.
Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., and Amigorena, S. (1999). Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371-380.
Reis e Sousa, C. (2004). Activation of dendritic cells: translating innate into adaptive immunity. Curr. Opin. Immunol. 16:21-25.
Rénia, L., Marañón, C., Hosmalin, A., Grüner, A. C., Silvie, O., and Snounou, G. (2005). Do apoptotic malaria infected hepatocytes initiate protective immune responses? J. Infect. Dis. 193:163-164.
Revy, P., Sospedra, M., Barbour, B., and Trautmann, A. (2001). Functional antigen-independent synapses formed between T cells and dendritic cells. Nat. Immunol. 2:925-931.
Rock, K. L. (2003). The ins and outs of cross-presentation. Nat. Immunol. 4:941- 943.
Rock, K. L., Hearn, A., Chen, C. J., and Shi, Y. (2005a). Natural endogenous adjuvants. Springer Semin. Immunopathol. 26:231-246.
Rock, K. L., and Shen, L. (2005b). Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207:166-183.
Salio, M., Cerundolo, V., and Lanzavecchia, A. (2000). Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. Eur. J. Immunol. 30:705-708.
Sallusto, F., Geginat, J., and Lanzavecchia, A. (2004). Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-763.
Sauter, B., Albert, M., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. (2000). Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423-433.
Saveanu, L., Fruci, D., and van Endert, P. (2002). Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases. Mol. Immunol. 39:203.
Savill, J., Gregory, C., and Haslett, C. (2003). Cell biology. Eat me or die. Science 302:1516-1517.
Scheinecker, C., McHugh, R., Shevach, E. M., and Germain, R. N. (2002). Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196:1079-1090.
Schmidt, B., Scott, I., Whitmore, R. G., Foster, H., Fujimura, S., Schmitz, J., and Levy, J. A. (2004). Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. Virology 329:280-288.
Schuler, G., and Steinman, R. M. (1997). Dendritic cells as adjuvants for immune- mediated resistance to tumors. J. Exp. Med. 186:1183-1187.
Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F., and Heard, J. M. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-342.
Seifert, U., Maranon, C., Shmueli, A., Desoutter, J. F., Wesoloski, L., Janek, K., Henklein, P., Diescher, S., Andrieu, M., de la Salle, H., Weinschenk, T., Schild, H., Laderach, D., Galy, A., Haas, G., Kloetzel, P. M., Reiss, Y., and Hosmalin, A. (2003). An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat. Immunol. 4:375-379.
Serna, A., Ramirez, M. C., Soukhanova, A., and Sigal, L. J. (2003). Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells. J. Immunol. 171:5668-5672.
Servet, C., Zitvogel, L., and Hosmalin, A. (2002). Dendritic cells in innate immune responses against HIV. Curr. Mol. Med. 2:739-756.
Shen, L., and Rock, K. L. (2004a). Cellular protein is the source of cross-priming antigen in vivo. Proc. Natl. Acad. Sci. U. S. A. 101:3035-3040.
Shen, L., Sigal, L. J., Boes, M., and Rock, K. L. (2004b). Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21:155-165.
Sigal, L. J., Crotty, S., Andino, R., and Rock, K. L. (1999). Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398:77-80.
Skoberne, M., Beignon, A. S., Larsson, M., and Bhardwaj, N. (2005). Apoptotic cells at the crossroads of tolerance and immunity. Curr. Top. Microbiol. Immunol. 289:259-292.
Smed-Sorensen, A., Lore, K., Walther-Jallow, L., Andersson, J., and Spetz, A. L. (2004). HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 104:2810-2817.
Somersan, S., and Bhardwaj, N. (2001). Tethering and tickling: a new role for the phosphatidylserine receptor. J. Cell. Biol. 155:501-504.
Spetz, A.-L., Patterson, B. K., Lore, K., Andersson, J., and Holmgren, L. (1999). Functional gene transfer of HIV DNA by an HIV receptor-independent mechanism. J. Immunol. 163:736-742.
Steinman, R., Turley, S., Melman, I., and Inaba, K. (2000). The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411-416.
Steinman, R. M., Hawiger, D., and Nussenzweig, M. C. (2003). Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
Stinchcombe, J. C., Bossi, G., Booth, S., and Griffiths, G. M. (2001). The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15:751-761.
Stumptner-Cuvelette, P., Morchoisne, S., Dugast, M., Le Gall, S., Raposo, G., Schwartz, O., and Benaroch, P. (2001). HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. U. S. A. 98:12144-12149.
Subauste, C. S., Wessendarp, M., Portilllo, J. A., Andrade, R. M., Hinds, L. M., Gomez, F. J., Smulian, A. G., Grubbs, P. A., and Haglund, L. A. (2004). Pathogen-specific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients. J. Infect. Dis. 189:61-70.
Tabiasco, J., Vercellone, A., Meggetto, F., Hudrisier, D., Brousset, P., and Fournie, J. J. (2003). Acquisition of viral receptor by NK cells through immunological synapse. J. Immunol. 170:5993-5998.
Thery, C., Zitvogel, L., and Amigorena, S. (2002). Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2:569-579.
Touret, N., Paroutis, P., Terebiznik, M., Harrison, R. E., Trombetta, S., Pypaert, M., Chow, A., Jiang, A., Shaw, J., Yip, C., Moore, H. P., van der Wel, N., Houben, D., Peters, P. J., de Chastellier, C., Mellman, I., and Grinstein, S. (2005). Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 123:157-170.
Townsend, A. R. M., Gotch, F. M., and Davey, J. (1985). Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42:457-467.
Turley, S., Poirot, L., Hattori, M., Benoist, C., and Mathis, D. (2003). Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198:1527-1537.
Turville, S. G., Cameron, P. U., Handley, A., Lin, G., Pohlmann, S., Doms, R. W., and Cunningham, A. L. (2002). Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3:975-983.
Vanham, G., Penne, L., Devalck, J., Kestens, R., Colebunders, R., Bosmans, E., Thielemans, K., and Ceuppens, J. (1999). Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin. Exp. Immunol. 117:335-342.
Veazey, R. S., and Lackner, A. A. (2004). Getting to the guts of HIV pathogenesis. J. Exp. Med. 200:697-700.
Watkins, S. C., and Salter, R. D. (2005). Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 23:309-318.
Weiss, L., Donkova-Petrini, V., Caccavelli, L., Balbo, M., Carbonneil, C., and Levy, Y. (2004). Human immunodeficiency virus-driven expansion of CD4+CD25+ Regulatory T cells which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104:3249-3256.
Wick, M. J., and Pfeifer, J. D. (1996). Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur. J. Immunol. 26:2790-2799.
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Thery, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., Angevin, E., Amigorena, S., and Zitvogel, L. (2001). Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7:297-303.
Wolkers, M. C., Brouwenstijn, N., Bakker, A. H., Toebes, M., and Schumacher, T. N. (2004). Antigen bias in T cell cross-priming. Science 304:1314-1317.
Yewdell, J. W., and Hill, A. B. (2002). Viral interference with antigen presentation. Nat. Immunol. 3:1019-1025.
Yewdell, J. W., Reits, E., and Neefjes, J. (2003). Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3:952-961.
Yonezawa, A., Morita, R., Takaori-Kondo, A., Kadowaki, N., Kitawaki, T., Hori, T., and Uchiyama, T. (2003). Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J. Virol. 77:3777-3784.
York, I. A., Goldberg, A. L., Mo, X. Y., and Rock, K. L. (1999). Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev. 172:49-66.
Yrlid, U., and Wick, M. J. (2002). Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter. J. Immunol. 169:108-116.
Zhang, R., Fichtenbaum, C. J., Hildeman, D. A., Lifson, J. D., and Chougnet, C. (2004). CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription. J. Immunol. 172:2678-2686.
Zhang, R., Lifson, J. D., and Chougnet, C. (2006). Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions. Blood 107:1989-1995.
Zhao, X. Q., Huang, X. L., Gupta, P., Borowski, L., Fan, Z., Watkins, S. C., Thomas, E. K., and Rinaldo, C. R., Jr. (2002). Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4- infected apoptotic cells. J. Virol. 76:3007-3014.
Zinkernagel, R. M., and Doherty, P. C. (1974). Restriction of in vitro T-cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogenic system. Nature 248:701-702.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Marañón, C., Hoeffel, G., ClaireRipoche, A., Hosmalin, A. (2007). Cross-Presentation by Dendritic Cells: Rolein HIV Immunity and Pathogenesis. In: Gessani, S., Belardelli, F. (eds) The Biology of Dendritic Cells and HIV Infection. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-33785-2_13
Download citation
DOI: https://doi.org/10.1007/978-0-387-33785-2_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-33784-5
Online ISBN: 978-0-387-33785-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)